Today's Research Reports on Centric Health, CRH Medical, Emerald Health Therapeutics and Titan Medical
NEW YORK, NY / ACCESSWIRE / June 14, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI Initiates Coverage on:
Centric Health Corporation
https://rdinvesting.com/news/?ticker=CHH.TO
CRH Medical Corporation
https://rdinvesting.com/news/?ticker=CRH.TO
Emerald Health Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=EMH.V
Titan Medical Inc.
https://rdinvesting.com/news/?ticker=TMD.TO
Centric Health's stock moved 3.51% lower Wednesday, to close the day at $0.28. The stock recorded a trading volume of 92,900 shares, which was below its three months average volume of 227,214 shares. In the last year, Centric Health's shares have traded in a range of 0.25 - 0.82. The stock is currently trading 66.46% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.34 is below its 200-day moving average of $0.46. Shares of the company are trading at a Price to Earnings ratio of 30.56. Shares of Centric Health have fallen approximately 47.12 percent year-to-date.
Access RDI's Centric Health Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CHH.TO
On Wednesday, shares of CRH Medical recorded a trading volume of 123,338 shares, which was below the three months average volume of 177,220 shares. The stock ended the day 0.43% higher at 4.68. The share price has gained 151.61% from its 52 week low with a 52 week trading range of 1.86 - 8.00. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.32 is greater than its 200-day moving average of $3.62. Shares of the company are trading at a Price to Earnings ratio of 54.42. Shares of CRH Medical have gained approximately 41.39 percent year-to-date.
Access RDI's CRH Medical Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CRH.TO
Emerald Health Therapeutics' stock moved 2.00% higher Wednesday, to close the day at $4.09. The stock recorded a trading volume of 346,163 shares, which was below its three months average volume of 673,459 shares. In the last year, Emerald Health Therapeutics' shares have traded in a range of 1.10 - 25.06. The share price has gained 271.82% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.42 is below its 200-day moving average of $5.25. Shares of Emerald Health Therapeutics have fallen approximately 21.5 percent year-to-date.
Access RDI's Emerald Health Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EMH.V
On Wednesday, shares of Titan Medical recorded a trading volume of 656,090 shares, which was above the three months average volume of 518,289 shares. The stock ended the day flat at 0.25. The share price has gained 92.31% from its 52 week low with a 52 week trading range of 0.13 - 0.68. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.25 is below its 200-day moving average of $0.33. Shares of Titan Medical have fallen approximately 34.21 percent year-to-date.
Access RDI's Titan Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TMD.TO
Our Actionable Research on Centric Health Corporation (TSX:CHH.TO) and CRH Medical Corporation (TSX:CRH.TO) and Emerald Health Therapeutics, Inc. (TSXV:EMH.V) and Titan Medical Inc. (TSX:TMD.TO) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com